Ignite Creation Date:
2024-05-06 @ 5:14 PM
Last Modification Date:
2024-10-26 @ 2:25 PM
Study NCT ID:
NCT05249712
Status:
RECRUITING
Last Update Posted:
2023-01-03
First Post:
2022-02-10
Brief Title:
Efficacy and Safety of Darolutamide Combined With ADT in High-riskVery High-risk Localized Prostate Cancer
Sponsor:
Organization:
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School